when patients test as having borderline high-risk smoldering myeloma, should they receive treatment?
Published 3 years ago • 1.6K plays • Length 5:27Download video MP4
Download video MP3
Similar videos
-
4:47
what is high-risk smoldering myeloma? criteria, risks, and ongoing research
-
4:04
how is high-risk smoldering multiple myeloma diagnosed?
-
4:12
when should smoldering multiple myeloma patients start treatment?
-
58:44
treatments available for high risk smoldering myeloma patients
-
3:16
should smoldering myeloma patients start treatment?
-
4:40
how do the two approaches to treating high-risk smoldering multiple myeloma (hrsmm) patients differ?
-
1:26
identifying high-risk smoldering myeloma & minimizing treatment-related toxicity
-
2:45
clinical and genomic diagnosis of smoldering myeloma & identifying patients at risk of progression
-
2:34
how should smoldering multiple myeloma be monitored?
-
9:55
curative strategy for high-risk smoldering myeloma: post-hoc analysis of sustained undetectable mrd
-
3:48
the importance of treating patients with smoldering myeloma at high risk of progression to myeloma
-
3:59
when should a myeloma patient begin treatment?
-
0:26
who is high-risk smoldering myeloma | dr. s. vincent rajkumar
-
22:28
case 1: patient with high-risk smoldering myeloma
-
6:19
high risk and smoldering multiple myeloma
-
4:03
imf ceo yelak biru shares his myeloma patient story
-
1:04
better understanding smoldering myeloma & improving the outcomes of patients with high-risk myeloma
-
2:04
ash 2018: earlier smoldering myeloma treatment & the promise study
-
28:19
international myeloma workshop 2021 | daily update, part 2 | car-t cell therapy smoldering mm